<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Risks of ending disease-modifying therapy may be ‘minimal’ in older, stable adults with MS

Default sub title

minute read

by Healio | February 28, 2025
placeholder

Topics: Press Coverage